Sofiva Genomics Co.,Ltd. (TPEX:6615)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
33.70
-0.35 (-1.03%)
Apr 2, 2026, 1:18 PM CST
Market Cap727.70M -18.8%
Revenue (ttm)385.71M -14.9%
Net Income-9.36M
EPS-0.43
Shares Out21.59M
PE Ration/a
Forward PEn/a
Dividend0.30 (0.89%)
Ex-Dividend DateJun 27, 2025
Volume40,247
Average Volume31,588
Open34.10
Previous Close34.05
Day's Range33.50 - 34.10
52-Week Range28.90 - 38.10
Beta0.26
RSI43.72
Earnings DateMay 15, 2026

About Sofiva Genomics

Sofiva Genomics Co.,Ltd. provides pre-pregnancy, prenatal, and newborn genetic testing and medical testing services in Taiwan and internationally. The company offers reproductive testing services, including preimplantation genetic testing for aneuploidy (PGT-A), non-invasive preimplantation genetic testing for aneuploidy (niPGT-A), and preimplantation genetic testing for monogenic diseases (PGT-M); and prenatal testing services, such as non-invasive prenatal screening, array, karyotyping, maternal serum screening for down syndrome, risk assessm... [Read more]

Sector Healthcare
Founded 2012
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 6615
Full Company Profile

Financial Performance

Financial Statements